drugset / Trial / NCT04897984
LEAP2 Kinetics in Healthy Individuals
NaSingle-groupOpen-labelTreatment
Summary
The study aims to investigate the kinetics of the naturally occurring peptide liver-enriched antimicrobial peptide 2 (LEAP-2) in healthy volunteers. The overall objective is to investigate the physiological importance of LEAP-2 in healthy subjects.
Timeline
- Start
- 2021-05-24
- Primary completion
- 2021-06-25
- Completion
- 2021-06-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LEAP2 | Peptide | — | Intravenous |